Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
LYVDELZI Kaps 10 mg 30 Stk
Drug
Lyvdelzi, Hartkapseln
Behandlung der primären biliären Cholangitis
04.99.0. – various
HAM – Human medicine
KAHA – Capsule, hard
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
B – limited
12/9/2025
12/9/2027
Dosage strength
Lyvdelzi 10 mg, Hartkapseln
Behandlung der primären biliären Cholangitis
01
B – limited
Package
7680700630016
In trade from / since 1/12/2026
A/R – Authorised / referenced
30 capsule(s)
001
B – limited
Declaration
Component
10 mg seladelparum
seladelparum lysinum dihydricum
seladelparum lysinum dihydricum
mannitolum
cellulosum microcristallinum
carmellosum natricum conexum
0.42 mg natrium
magnesii stearas
silica colloidalis anhydrica
E 321
gelatina
E 171
E 172 (nigrum)
E 172 (flavum)
E 172 (rubrum)
E 132
lacca
propylenglycolum
kalii hydroxidum
E 172 (nigrum)
lacca
propylenglycolum
natrii hydroxidum
povidonum
E 171
cellulosum microcristallinum
carmellosum natricum conexum
0.42 mg natrium
magnesii stearas
silica colloidalis anhydrica
E 321
gelatina
E 171
E 172 (nigrum)
E 172 (flavum)
E 172 (rubrum)
E 132
lacca
propylenglycolum
kalii hydroxidum
E 172 (nigrum)
lacca
propylenglycolum
natrii hydroxidum
povidonum
E 171
Authorisation holder
7601001379374
Gilead Sciences Switzerland Sàrl
General-Guisan-Strasse 8
6300 Zug (ZG)
General-Guisan-Strasse 8
6300 Zug (ZG)
Date of revision of the text
1/13/2026
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.